Single-cell profiling aligns CD56bright and cytomegalovirus-induced adaptive natural killer cells to a naïve-memory relationship

Front Immunol. 2024 Dec 17:15:1499492. doi: 10.3389/fimmu.2024.1499492. eCollection 2024.

Abstract

Development of antigen-specific memory upon pathogen exposure is a hallmark of the adaptive immune system. While natural killer (NK) cells are considered part of the innate immune system, humans exposed to the chronic viral pathogen cytomegalovirus (CMV) often possess a distinct NK cell population lacking in individuals who have not been exposed, termed "adaptive" NK cells. To identify the "naïve" population from which this "memory" population derives, we performed phenotypic, transcriptional, and functional profiling of NK cell subsets. We identified immature precursors to the Adaptive NK cells that are equally present in both CMV+ and CMV- individuals, resolved an Adaptive transcriptional state distinct from most mature NK cells and sharing a common gene program with the immature CD56bright population, and demonstrated retention of proliferative capacity and acquisition of superior IFNγ production in the Adaptive population. Furthermore, we distinguish the CD56bright and Adaptive NK populations by expression of the transcription factor CXXC5, positioning these memory NK cells at the inflection point between innate and adaptive lymphocytes.

Keywords: HCMV (human cytomegalovirus); human immunology; innate memory; lymphocyte development and function; natural killer cell (NK cells); single-cell RNA (scRNA) sequencing.

MeSH terms

  • Adaptive Immunity*
  • CD56 Antigen* / metabolism
  • Cytomegalovirus Infections* / immunology
  • Cytomegalovirus Infections* / virology
  • Cytomegalovirus* / immunology
  • Humans
  • Immunologic Memory*
  • Killer Cells, Natural* / immunology
  • Killer Cells, Natural* / metabolism
  • Single-Cell Analysis*

Substances

  • CD56 Antigen
  • NCAM1 protein, human

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. These studies were funded by NIH R01 AI150999 and U01 AI069197, and the MSKCC Human Oncology and Pathogenesis Program. SG is the recipient of a CRI/Donald J. Gogel Fellowship (CRI #3934).